Literature DB >> 25705272

Detection of highly ciprofloxacin resistance acinetobacter baumannii isolated from patients with burn wound infections in presence and absence of efflux pump inhibitor.

Mohammad-Hossein Maleki1, Farid Azizi Jalilian2, Hatef Khayat3, Maryam Mohammadi3, Fazel Pourahmad4, Khairollah Asadollahi5, Iraj Pakzad2, Nourkhoda Sadeghifard2, Setareh Soroush2, Mohammad Emaneini6, Morovat Taherikalani2.   

Abstract

The emergence of fluoroquinolone resistance among A. baumannii isolates is now of particular concern. Phenotypic and genotypic characteristics of resistance to ciprofloxacin among 50 Acinetobacter baumannii isolated from burn wound infections of Tehran were evaluated by E-test and broth microdilution in presence and absence of efflux pump inhibitor phenylalanine- arginine β-naphthylamide (PAβN) and PCR-sequencing methods. All isolates were then typed by REP-PCR fingerprinting to find the clonal relationship between resistant isolates. Our results indicated that resistance to ciprofloxacin among A. baumannii isolated from burn infections in Tehran are high with resistance rate of 100% and ciprofloxacin resistant isolates have a mutation of Serine 83 →Leucine in the quinolone resistance determining region (QRDR) of DNA gyrase subunit A (GyrA). 38% of the isolates showed MIC ranges of 64 to ≥512μg/ml and were considered as highly resistant. We could not detect Par C mutations and plasmid-mediated quinolone resistance A (qnrA) among ciprofloxacin resistant isolates. When we used the efflux pump inhibitor PAbN, MIC of ciprofloxacin was reduced two-to four folds. REP-type A (25/50; 50%), B (20/50; 30%) and C (10/50; 20%) were the most common REP-types among A. baumannii isolates. It seems that mutation in GyrA is the main mechanism of resistant to ciprofloxacin among A. baumannii isolates from burn infections and presence of efflux pumps is just secondary target for ciprofloxacin resistant among A. baumannii in Iran. Regarding with limitation of REP-types detected in this study, we found good correlation between resistance to ciprofloxacin and REP-types A-C.

Entities:  

Keywords:  A. baumannii; ciprofloxacin resistance; gyr A QRDRS

Year:  2014        PMID: 25705272      PMCID: PMC4296759     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  23 in total

1.  Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin.

Authors:  Ahmed Hamouda; Sebastian G B Amyes
Journal:  J Antimicrob Chemother       Date:  2004-07-28       Impact factor: 5.790

2.  Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea.

Authors:  Jeom Kyu Lee; Yeong Seon Lee; Yong Keun Park; Bong Su Kim
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

3.  Class 1 integron gene cassettes in multidrug-resistant Gram-negative bacteria in southern China.

Authors:  Kuihai Wu; Fengping Wang; Jingjing Sun; Qian Wang; Qing Chen; Shouyi Yu; Yongyu Rui
Journal:  Int J Antimicrob Agents       Date:  2012-07-19       Impact factor: 5.283

4.  Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.

Authors:  Jing Gao; Xiaonan Zhao; Ying Bao; Ruihua Ma; Yufa Zhou; Xinxian Li; Tongjie Chai; Yumei Cai
Journal:  Burns       Date:  2013-07-22       Impact factor: 2.744

5.  Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide.

Authors:  Stefanie Pannek; Paul G Higgins; Petra Steinke; Daniel Jonas; Murat Akova; Jürgen A Bohnert; Harald Seifert; Winfried V Kern
Journal:  J Antimicrob Chemother       Date:  2006-03-10       Impact factor: 5.790

6.  Nosocomial infection characteristics in a burn intensive care unit: analysis of an eleven-year active surveillance.

Authors:  Oral Öncül; Sinan Öksüz; Ali Acar; Ersin Ülkür; Vedat Turhan; Fatih Uygur; Asım Ulçay; Hakan Erdem; Mustafa Özyurt; Levent Görenek
Journal:  Burns       Date:  2013-12-02       Impact factor: 2.744

7.  First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals.

Authors:  Abdelaziz Touati; Lucien Brasme; Said Benallaoua; Alima Gharout; Janick Madoux; Christophe De Champs
Journal:  Diagn Microbiol Infect Dis       Date:  2007-11-26       Impact factor: 2.803

8.  Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii.

Authors:  Richard P Spence; Kevin J Towner
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

9.  Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; J Ruiz; P Goñi; A Marcos; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

10.  Blood stream infections in patients in the burn intensive care unit.

Authors:  Hun Gu Lee; Juah Jang; Jeong Eun Choi; Doo Cheol Chung; Jung Wan Han; Heungjeong Woo; Wook Jeon; Byung Chul Chun
Journal:  Infect Chemother       Date:  2013-06-26
View more
  5 in total

Review 1.  SOS response and its regulation on the fluoroquinolone resistance.

Authors:  Ting-Ting Qin; Hai-Quan Kang; Ping Ma; Peng-Peng Li; Lin-Yan Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-12

2.  Molecular Detection of Adefg Efflux Pump Genes and their Contribution to Antibiotic Resistance in Acinetobacter baumannii Clinical Isolates.

Authors:  Rasoul Kaviani; Iman Pouladi; Mohammad Niakan; Reza Mirnejad
Journal:  Rep Biochem Mol Biol       Date:  2020-01

3.  A Severe Accident Caused by an Ocellate River Stingray (Potamotrygon motoro) in Central Brazil: How Well Do We Really Understand Stingray Venom Chemistry, Envenomation, and Therapeutics?

Authors:  Nelson Jorge da Silva; Kalley Ricardo Clementino Ferreira; Raimundo Nonato Leite Pinto; Steven Douglas Aird
Journal:  Toxins (Basel)       Date:  2015-06-18       Impact factor: 4.546

4.  Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients.

Authors:  Samira M Hamed; Walid F Elkhatib; Hadir A El-Mahallawy; Mai M Helmy; Mohamed S Ashour; Khaled M A Aboshanab
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

5.  Bacteria richness and antibiotic-resistance in bats from a protected area in the Atlantic Forest of Southeastern Brazil.

Authors:  Vinícius C Cláudio; Irys Gonzalez; Gedimar Barbosa; Vlamir Rocha; Ricardo Moratelli; Fabrício Rassy
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.